
Apple loses bid to overturn $634M Masimo judgment
Apple has failed in its attempt to overturn a $634 million judgment in its dispute with Masimo concerning Apple Watch technology.
27 stories found

Apple has failed in its attempt to overturn a $634 million judgment in its dispute with Masimo concerning Apple Watch technology.
QuidelOrtho has announced the appointment of Micah Young, a former executive from Masimo, as its new Chief Financial Officer.
Articles evaluate the investment prospects of National HealthCare Corporation (NHC), TC Energy Corporation (TRP), and Masimo Corporation (MASI) to assess their current suitability as stock purchases.
Danaher Corporation (DHR) is reportedly considering an all-cash deal for Masimo, which is seen as a strong strategic fit for the company.
Naya Capital has announced an increase in its holdings of Masimo shares, indicating a strategic investment move.

Danaher shares fell on the news that it was acquiring medtech player Masimo.

The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.
Danaher has acquired Masimo for $9.9 billion, a significant move in the medical technology sector.
Danaher Strikes $10 Billion Deal for Masimo The Wall Street Journal
Danaher (DHR) has finalized its acquisition of Masimo Corporation for $9.9 billion, completing a significant transaction in the life sciences and diagnostics industry.

Renowned architecture and interior photographer Massimo Listri is set to showcase his exclusive exhibition, 'Interni Italijani,' at the City Museum Salon in Belgrade, running from May 20 to June 15.
Masimo, a medical technology company, has landed a $100 million contract modification for an existing monitoring deal.
This week's notable healthcare headlines highlight developments concerning major companies such as Johnson & Johnson, Masimo, and Bayer.
Danaher's acquisition of Masimo for $9.9 billion marks one of the largest medtech buyouts anticipated for 2026.
Danaher has announced the acquisition of Masimo for $9.9 billion, a move aimed at strengthening its diagnostics business.

Warner Bros has given Paramount a week to submit its 'best and final' offer, as Netflix grants a waiver to a rival bidder in a high-stakes battle for control.
Danaher has announced its intention to acquire Masimo in a deal valued at $9.9 billion.
Danaher Corporation has announced its intention to acquire Masimo for $9.9 billion, a strategic move aimed at bolstering its diagnostics portfolio.
The article analyzes Danaher's stock performance, which is down 22% this year, and questions whether its acquisition of Masimo presents an opportune entry point for investors. It likely evaluates the acquisition's impact and future potential for the company.
Masimo Corporation (MASI) saw its stock rise significantly following the announcement of an acquisition, indicating positive investor reaction to the deal.
An investor reportedly sold a $7 million stake in Masimo just prior to the company's stock experiencing a 34% surge following a $9.9 billion acquisition announcement.
Medallion Financial aims for mid-teens loan growth by 2026, driven by an expanding home improvement segment and a leadership transition.
Masimo (MASI) shares surged 34% following the announcement of a $9.9 billion merger with Danaher.
Danaher has agreed to acquire Masimo, a medical technology firm, in a deal valued at $9.9 billion.
Danaher Strikes $10 Billion Deal for Masimo The Wall Street Journal
A list of premarket movers in the US includes Danaher, Fiserv, General Mills, Masimo, and Zim, indicating early trading activity.

Danaher is reportedly close to acquiring Masimo, a medical technology company involved in an intellectual property dispute with Apple, for nearly $10 billion.